TUESDAY, SEPTEMBER 27, 2016

Flu widespread in Rhode Island

The Rhode Island Department of Health (HEALTH) recently made a Declaration of Widespread Flu Incidence Statewide across Rhode Island. Read More »

CBCD reports HPV not a disease, but rather an infection

Fox News is claiming the human papillomavirus is not a sexually transmitted disease, but instead, a sexually transmitted infection. Read More »

New research yields possible solution to fighting EV-D68

New research conducted at Purdue University has found a class of compounds that may be effective in fighting infections caused by enterovirus D68. Read More »

Walgreens releases latest data on flu activity

Walgreens released its most recent flu index for the week that began on Dec. 29. Read More »

Soligenix's Macrophage Activation Syndrome study shows promise

Soligenix, Inc., a biopharmaceutical company that focuses on biodefense, inflammation, and oncology, recently completed a successful study of a Macrophage Activation Syndrome (MAS) treatment. Read More »

Obama thanks NIH scientists

President Barack Obama visited the National Institutes of Health (NIH) on Dec. 2 to congratulate scientists for developing a potential vaccine against Ebola. Read More »

Emory study shows HIV vaccines actually have reverse results

Scientists at Emory University’s Yerkes National Primate Research Center recently published results of a study that detail how vaccines designed to protect against HIV can actually backfire and lead to infection. Read More »

Pfizer obtains herpes vaccine candidate from Redvax

Pfizer recently announced that it has acquired a controlling interest in Redvax GmbH, a spin-off from Redbiotec AG, a Swiss biopharmaceutical company. Read More »

Proactive prevention stops spread of avian flu

The spread of A H7N9, an influenza strain commonly known as avian flu, has been stopped in Hong Kong thanks to proactive preventative measures taken by health care professionals. Read More »

NIAID hiring associate chief

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Insitutes of Health, is hiring an associate chief for clinical trials operations at its Vaccine Research Center. Read More »

Yale study finds cold virus thrives in cooler areas of body

A new Yale University study released Monday suggests the common cold virus can reproduce itself more efficiently in cooler temperatures found inside the nose than in the body's warmer core areas. Read More »

NIH Ebola test vaccine shows promise in early trials

An experimental vaccine to prevent the Ebola virus has shown positive results among a 20-adult sample size, the National Institutes of Health (NIH) said in its January newsletter. Read More »

Jan. 5 Walgreens Flu Index

This week’s report from the Walgreens Flu Index™ shows that the city with the highest rates of flu activity is Knoxville, Tennessee and the state with the most flu activity is Kentucky. Read More »

Genocea completes enrollment in Phase 2 genital herpes trial

Researchers from Genocea Biosciences, Inc. recently finished enrollment for a Phase 2 clinical trial study of dose optimization for GEN-003, a treatment for genital herpes. Read More »

New research shows HPV vaccine not a cause for MS

Some research has linked the human papillomavirus vaccination (HPV) to the development of multiple sclerosis (MS), but a recent study in Scandinavia shows this isn’t the case. Read More »

FDA approves wider use of Alere i Influenza A & B test

The U.S. Food and Drug Administration (FDA) granted the first waiver to allow a nucleic acid-based test -- the Alere i Influenza A&B test -- to be used in general health care settings on Tuesday. Read More »

Vaxart raises $18.4 million for Ebola, norovirus tablet vaccines

Vaxart, Inc., recently raised $18.4 million in additional funding that will allow it to begin Phase 1 clinical trials for tablet vaccines rather than injection vaccines for norovirus and Ebola. Read More »

Targovax testing vaccine for inoperable pancreatic cancer

Targovax, a biopharmaceutical oncology company based in Norway, recently recruited 18 patients with inoperable pancreatic cancer for the Phase I/II clinical trial of its TG01 vaccine. Read More »

Inhalable vaccines for lung diseases on the horizon

Researchers at the University of North Carolina at Chapel Hill and North Carolina State University have discovered a unique approach to creating inhalable vaccines for pneumonia and influenza. Read More »

Study shows increased T cells can help HIV infection

Researchers at John Hopkins University recently looked at whether awakening latent CD4+ T cells so that they could begin making HIV-fighting proteins would backfire and ultimately kill the otherwise dormant cells where the HIV virus hides. Read More »